GLP-1 medications like Zepbound weren't designed for smoking cessation — but there's growing interest in whether the same brain pathways they affect for food cravings might also influence addictive behaviors like nicotine dependence.
What we know about the mechanism:
What's still unclear:
What this means practically:
This is a genuinely interesting area of ongoing research, but it's not ready to drive treatment decisions. **Talk to your provider** about proven cessation strategies that can work alongside your current medications.
Different ways people phrase this question. Each expands to the same answer.
GLP-1 medications like Zepbound weren't designed for smoking cessation — but there's growing interest in whether the same brain pathways they affect for food cravings might also influence addictive behaviors like nicotine dependence.
What we know about the mechanism:
What's still unclear:
What this means practically:
This is a genuinely interesting area of ongoing research, but it's not ready to drive treatment decisions. **Talk to your provider** about proven cessation strategies that can work alongside your current medications.
GLP-1 medications like Zepbound weren't designed for smoking cessation — but there's growing interest in whether the same brain pathways they affect for food cravings might also influence addictive behaviors like nicotine dependence.
What we know about the mechanism:
What's still unclear:
What this means practically:
This is a genuinely interesting area of ongoing research, but it's not ready to drive treatment decisions. **Talk to your provider** about proven cessation strategies that can work alongside your current medications.
GLP-1 medications like Zepbound weren't designed for smoking cessation — but there's growing interest in whether the same brain pathways they affect for food cravings might also influence addictive behaviors like nicotine dependence.
What we know about the mechanism:
What's still unclear:
What this means practically:
This is a genuinely interesting area of ongoing research, but it's not ready to drive treatment decisions. **Talk to your provider** about proven cessation strategies that can work alongside your current medications.